| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.09. | AI Isn't a Therapist, but Many Teens Are Treating It Like One | ||
| 16.09. | Hospital Margins Fell This Summer Amid Outpatient Slowdown, Data Shows | ||
| 16.09. | Thatch Secures $108M, Reaches $1B Valuation | ||
| 15.09. | GSK Commits $750M to Get Chimagen's Phase 1-Ready Drug for Multiple Myeloma | ||
| 15.09. | The Real Bottleneck in U.S. Pharma Reshoring Isn't Factories - It's Talent | ||
| 15.09. | How Human-Led AI Improves Healthcare Marketing Intelligence | ||
| 14.09. | Nara Health Secures $14M for Third Party Administration Platform | ||
| 14.09. | Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease | ||
| 14.09. | Shadow AI Is the Fastest Growing Force in Medicine, and Hospitals Are the Only Ones Who Can Control It | ||
| 14.09. | From Onboarding to Outcomes: The Privacy-First Identity Workflow for Pharma Marketing | ||
| 14.09. | Interra Health Adds GLP-1 Bridge Program Support | ||
| 13.09. | Inspiren Rakes In $70M to Scale Its AI-Powered Senior Living Platform | ||
| 13.09. | Healthcare Needs Software That Handles a Messy Reality | ||
| 11.09. | GenHealth.ai Raises $16.5M to Automate Healthcare Administrative Tasks | ||
| 11.09. | Nutromics Nabs FDA Breakthrough Status for Antibiotic Monitoring Patch | ||
| 11.09. | Augmenting the Systems That Support Patient Mobility | ||
| 11.09. | 3 Strategies to Improve Health Insurance, Per Georgetown Report | ||
| 11.09. | At INVEST Digital Health, Health Wildcatters Will Highlight Latest Cohort of Startups | ||
| 11.09. | Imprivata CEO: AI Agents Need the Same Scrutiny as an Unvetted Contract Nurse | ||
| 10.09. | What Health Equity Champions Can Learn from Pharmaceutical Sales | ||
| 10.09. | Healthcare Executives Weigh In: AI Readiness and the Growing Risk of Cybersecurity Threats | ||
| 10.09. | Virtual CKD Solutions Don't Slow Disease Progression or Reduce Costs, Report Finds | ||
| 09.09. | How Lifepoint Health Is Using AI to Give Nurses Their Time Back | ||
| 09.09. | Ethics Isn't a Pharma Value - It's a Competitive Moat | ||
| 09.09. | Forus Secures $150M Series C, Reaches $3B Valuation |